Technical Analysis for CUR - Neuralstem, Inc.

Grade Last Price % Change Price Change
grade F 0.4575 -1.06% 0.00
CUR closed down 1.06 percent on Friday, May 24, 2019, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Flat
See historical CUR trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
20 DMA Resistance Bearish -1.06%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.06%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.54%
Earnings Movers Other -0.54%
Inside Day Range Contraction -0.54%
Earnings Movers Other 1.64%
Inside Day Range Contraction 1.64%

Older signals for CUR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Neuralstem, Inc., a biopharmaceutical company, focuses on the development and commercialization of treatments for central nervous system disease based on human neural stem cells and the use of small molecule compounds. Its stem cell technology enables the isolation and expansion of human neural stem cells from various areas of the developing human brain and spinal cord enabling the generation of physiologically relevant human neurons. Its products under development include NSI – 566, which has completed Phase I clinical trial for the proposed treatment of amyotrophic lateral sclerosis, as well as for chronic spinal cord injury and motor deficits due to ischemic stroke; and NSI – 189, a small molecule pharmaceutical compound, which is in Phase Ib clinical trial for the treatment of major depressive disorder. Neuralstem, Inc. was founded in 1996 and is headquartered in Rockville, Maryland.
Biotechnology Biopharmaceutical Life Sciences Biology Stem Cells Amyotrophic Lateral Sclerosis Major Depressive Disorder Stem Cell Therapy Treatment Of Major Depressive Disorder Ischemic Stroke
Is CUR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 1.78
52 Week Low 0.25
Average Volume 238,526
200-Day Moving Average 0.6416
50-Day Moving Average 0.4781
20-Day Moving Average 0.4722
10-Day Moving Average 0.4563
Average True Range 0.05
ADX 14.96
+DI 13.4569
-DI 19.387
Chandelier Exit (Long, 3 ATRs ) 0.398
Chandelier Exit (Short, 3 ATRs ) 0.54
Upper Bollinger Band 0.5361
Lower Bollinger Band 0.4083
Percent B (%b) 0.38
BandWidth 27.064803
MACD Line -0.0062
MACD Signal Line -0.0056
MACD Histogram -0.0006
Fundamentals Value
Market Cap 5.54 Million
Num Shares 12.1 Million
EPS -2.22
Price-to-Earnings (P/E) Ratio -0.21
Price-to-Sales 977.06
Price-to-Book 2.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.49
Resistance 3 (R3) 0.49 0.48 0.49
Resistance 2 (R2) 0.48 0.47 0.48 0.48
Resistance 1 (R1) 0.47 0.47 0.46 0.47 0.48
Pivot Point 0.46 0.46 0.45 0.46 0.46
Support 1 (S1) 0.45 0.45 0.44 0.45 0.43
Support 2 (S2) 0.43 0.44 0.43 0.43
Support 3 (S3) 0.42 0.43 0.43
Support 4 (S4) 0.42